Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study

Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study

No Abstract available.

Bibliographic Details
Main Authors: Hyams, D., Chan, Arlene, de Oliveira, C., Snyder, R., Vinholes, J., Audeh, M W., Alencar, V., Lombard, J., Mookerjee, B., Xu, J., Brown, K., Klein, P.
Format: Journal Article
Published: Springer Science + Business Media 2013
Online Access:http://hdl.handle.net/20.500.11937/33934

Internet

http://hdl.handle.net/20.500.11937/33934

Similar Items